- Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin
[作者:Krikken, JA; Waanders, F; Dallinga-Thie, GM; Dikkeschei, LD; Vogt, L; Navis, GJ; Dullaart, RPF,期刊:Expert Opinion on Therapeutic Targets, 页码:497-504 , 文章类型: Article,,卷期:2009年13-5]
- Objective: Dyslipidemia contributes to increased cardiovascular risk in nephrotic syndrome. We questioned whether reduction in proteinuria not only lowers low-density lipoprotein cholesterol (LDL-C), but also high-densit...
- Resolvin E1 as a novel agent for the treatment of asthma
[作者:Hisada, T; Ishizuka, T; Aoki, H; Mori, M,期刊:Expert Opinion on Therapeutic Targets, 页码:513-522 , 文章类型: Review,,卷期:2009年13-5]
- Background: Asthma is characterized by airway hyperresponsiveness and chronic airway inflammation. Inflammatory cells, including eosinophils and lymphocytes, infiltrate peribronchial tissue in patients with asthma. Resol...
- Nephroprotective and clinical potential of statins in dialyzed patients
[作者:Rysz, J; Aronow, WS; Stolarek, RS; Hannam, S; Mikhailidis, DP; Banach, M,期刊:Expert Opinion on Therapeutic Targets, 页码:541-550 , 文章类型: Review,,卷期:2009年13-5]
- Background: The combination of increased cardiovascular mortality and vascular complications due to dyslipidaemia in chronic kidney disease (CKD) has focused attention onto the potential beneficial effects of 3-hydroxy-3...
|